27 January 2022
genXone will work with a Danish biotech company gMendel®
The innovative genXone company, operating in the biotech industry, has signed a letter of intent with gMendel® ApS, in which the companies have declared their willingness to cooperate in the future in the field of diagnosis of genetic disorders. The aim of cooperation is to lead to the modernization of the research process and increasing […]